Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 3/2004

01.03.2004 | Article

Risk Factors for the Development of Extended-Spectrum Beta-Lactamase-Producing Bacteria in Nonhospitalized Patients

verfasst von: R. Colodner, W. Rock, B. Chazan, N. Keller, N. Guy, W. Sakran, R. Raz

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 3/2004

Einloggen, um Zugang zu erhalten

Abstract

Although the risk factors for acquiring infection by extended-spectrum beta-lactamase (ESBL)-producing bacteria have been investigated in hospitalized patients, such risk factors have not been defined in the community setting. In this study, clinical data from a total of 311 nonhospitalized patients with community-acquired urinary tract infection (128 with ESBL-positive strains and 183 with ESBL-negative strains) were obtained. According to a multivariate analysis, the following were identified as independent risk factors: previous hospitalization in the past 3 months (OR=8.95, 95%CI, 3.77–21.25), antibiotic treatment in the past 3 months (OR=3.23, 95%CI, 1.76–5.91), age over 60 years (OR=2.65, 95%CI, 1.45–4.83), diabetes (OR=2.57, 95%CI, 1.20–5.51), male gender (OR=2.47, 95%CI, 1.22–5.01), Klebsiella pneumoniae infection (OR=2.31, 95%CI, 1.17–4.54), previous use of third-generation cephalosporins (P=0.014, OR=15.8, 95%CI, 1.7–143), previous use of second-generation cephalosporins (P<0.0001, OR=10.1, 95%CI, 4.2–24), previous use of quinolones (P=0.001, OR=4.1, 95%CI, 1.8–9.0), and previous use of penicillin (P=0.003, OR=4.0, 95%CI, 1.6–9.0).
Literatur
1.
Zurück zum Zitat Bush K (1996) Is it important to identify extended-spectrum beta-lactamase-producing isolates? Eur J Clin Microb Infect Dis 15:361–364 Bush K (1996) Is it important to identify extended-spectrum beta-lactamase-producing isolates? Eur J Clin Microb Infect Dis 15:361–364
2.
Zurück zum Zitat Shah PW, Stille W (1983) Escherichia coli and Klebsiella pneumoniae strains more susceptible to cefoxitin than to third-generation cephalosporins. J Antimicrob Chemother 11:597–598PubMed Shah PW, Stille W (1983) Escherichia coli and Klebsiella pneumoniae strains more susceptible to cefoxitin than to third-generation cephalosporins. J Antimicrob Chemother 11:597–598PubMed
3.
Zurück zum Zitat Jarlier V, Nicolas MH, Fournier G, Philippon A (1988) Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility pattern. Rev Infect Dis 10:867–878PubMed Jarlier V, Nicolas MH, Fournier G, Philippon A (1988) Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility pattern. Rev Infect Dis 10:867–878PubMed
4.
Zurück zum Zitat Jacoby GA, Medeiros AA, O’Brien TF, Pinto ME, Jiang H (1988) Broad-spectrum, transmissible beta-lactamases. N Engl J Med 319:723–724PubMed Jacoby GA, Medeiros AA, O’Brien TF, Pinto ME, Jiang H (1988) Broad-spectrum, transmissible beta-lactamases. N Engl J Med 319:723–724PubMed
5.
Zurück zum Zitat Quinn JP, Miyashiro D, Sahm D, Flamm R, Bush K (1989) Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemoter 33:1451–1456 Quinn JP, Miyashiro D, Sahm D, Flamm R, Bush K (1989) Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemoter 33:1451–1456
6.
Zurück zum Zitat Paterson DL, Mulazimoglu L, Casellas JM, Ko WC, Goossens H, Von Gottberg A, Mohapatra S, Trenholme GM, Klugman KP, McCormack JG, Yu VL (2000) Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. Clin Infect Dis 30:473–478CrossRefPubMed Paterson DL, Mulazimoglu L, Casellas JM, Ko WC, Goossens H, Von Gottberg A, Mohapatra S, Trenholme GM, Klugman KP, McCormack JG, Yu VL (2000) Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. Clin Infect Dis 30:473–478CrossRefPubMed
7.
Zurück zum Zitat Rice LB (1999) Successful interventions for gram-negative resistance to extended-spectrum beta-lactam antibiotics. Pharmacotheropy 19 (8 Pt 2):120S–128S Rice LB (1999) Successful interventions for gram-negative resistance to extended-spectrum beta-lactam antibiotics. Pharmacotheropy 19 (8 Pt 2):120S–128S
8.
Zurück zum Zitat Pena C, Pujol M, Ricart A, Ardanuy C, Ayats J, Linares J, Garrigosa F, Ariza J, Gudiol F (1997) Risk factors for faecal carriage of Klebsiella pneumoniae producing extended-spectrum beta-lactamase in the intensive care unit. J Hosp Infect 35:9–16PubMed Pena C, Pujol M, Ricart A, Ardanuy C, Ayats J, Linares J, Garrigosa F, Ariza J, Gudiol F (1997) Risk factors for faecal carriage of Klebsiella pneumoniae producing extended-spectrum beta-lactamase in the intensive care unit. J Hosp Infect 35:9–16PubMed
9.
Zurück zum Zitat Ho PL, Chan WM, Tsang KW, Wong SS, Young K (2002) Extended-spectrum beta-lactamases: frequency, risk factors, and outcomes. Pharmacotherapy 22:14–20PubMed Ho PL, Chan WM, Tsang KW, Wong SS, Young K (2002) Extended-spectrum beta-lactamases: frequency, risk factors, and outcomes. Pharmacotherapy 22:14–20PubMed
10.
Zurück zum Zitat Mangeney N, Niel P, Paul G, Faubert E, Hue S, Dupeyron C, Louarn F, Leluan G (2000) A 5-year epidemiological study of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates in a medium- and long-stay neurological unit. J Appl Microbiol 88:504–511CrossRefPubMed Mangeney N, Niel P, Paul G, Faubert E, Hue S, Dupeyron C, Louarn F, Leluan G (2000) A 5-year epidemiological study of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates in a medium- and long-stay neurological unit. J Appl Microbiol 88:504–511CrossRefPubMed
11.
Zurück zum Zitat Barrett SP, Savage MA, Rebec MP, Guyot A, Andrews N, Shrimpton SB (1999) Antibiotic sensitivity of bacteria associated with community-acquired urinary tract infection in Britain. J Antimicrob Chem 44:359–365CrossRef Barrett SP, Savage MA, Rebec MP, Guyot A, Andrews N, Shrimpton SB (1999) Antibiotic sensitivity of bacteria associated with community-acquired urinary tract infection in Britain. J Antimicrob Chem 44:359–365CrossRef
12.
Zurück zum Zitat Colodner R, Keness Y, Chazan B, Raz R (2001) Antimicrobial susceptibility of community-acquired uropathogens in northern Israel. Int J Antimicrob Agents 18:189–192 Colodner R, Keness Y, Chazan B, Raz R (2001) Antimicrobial susceptibility of community-acquired uropathogens in northern Israel. Int J Antimicrob Agents 18:189–192
13.
Zurück zum Zitat Clarridge JE, Johnson JR, Pezzlo, AM (1998) Laboratory diagnosis of urinary tract infections. Cumitech 2B. American Society for Microbiology Press, Washington DC Clarridge JE, Johnson JR, Pezzlo, AM (1998) Laboratory diagnosis of urinary tract infections. Cumitech 2B. American Society for Microbiology Press, Washington DC
14.
Zurück zum Zitat National Committee for Clinical Laboratory Standards (2002) Performance standards for antimicrobial susceptibility testing. Twelfth informational supplement. Document M100-S12. NCCLS, Wayne, PA, p 39 National Committee for Clinical Laboratory Standards (2002) Performance standards for antimicrobial susceptibility testing. Twelfth informational supplement. Document M100-S12. NCCLS, Wayne, PA, p 39
15.
Zurück zum Zitat Borer A, Gilad J, Menashe G, Peled N, Riesenberg K, Schlaeffer F (2002) Extended-spectrum beta-lactamase-producing Enterobacteriaceae strains in community-acquired bacteremia in southern Israel. Med Sci Monit 8:44–47 Borer A, Gilad J, Menashe G, Peled N, Riesenberg K, Schlaeffer F (2002) Extended-spectrum beta-lactamase-producing Enterobacteriaceae strains in community-acquired bacteremia in southern Israel. Med Sci Monit 8:44–47
16.
Zurück zum Zitat Raz R, Okev N, Kennes Y, Gilboa A, Lavi I, Bisharat N (2000) Demographic characteristics of patients with community-acquired bacteriuria and susceptibility of urinary pathogens to antimicrobials in northern Israel. Isr Med Assoc J 2:426–429PubMed Raz R, Okev N, Kennes Y, Gilboa A, Lavi I, Bisharat N (2000) Demographic characteristics of patients with community-acquired bacteriuria and susceptibility of urinary pathogens to antimicrobials in northern Israel. Isr Med Assoc J 2:426–429PubMed
17.
Zurück zum Zitat Bisson G, Fishman NO, Patel JB, Edelstein PH, Lautenbach E (2002) Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species: risk factors for colonization and impact of antimicrobial formulary interventions on colonization prevalence. Infect Control Hosp Epidemiol 23:254–260PubMed Bisson G, Fishman NO, Patel JB, Edelstein PH, Lautenbach E (2002) Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species: risk factors for colonization and impact of antimicrobial formulary interventions on colonization prevalence. Infect Control Hosp Epidemiol 23:254–260PubMed
18.
Zurück zum Zitat Wiener J, Quinn JP, Bradford PA, Goering RV, Nathan C, Bush K, Weinstein RA (1999) Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA 281:517–523CrossRefPubMed Wiener J, Quinn JP, Bradford PA, Goering RV, Nathan C, Bush K, Weinstein RA (1999) Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA 281:517–523CrossRefPubMed
19.
Zurück zum Zitat Meyer KS, Urban C, Eagan JA, Berger BJ, Rahal JJ (1993) Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins. Ann Intern Med 119:353–358PubMed Meyer KS, Urban C, Eagan JA, Berger BJ, Rahal JJ (1993) Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins. Ann Intern Med 119:353–358PubMed
Metadaten
Titel
Risk Factors for the Development of Extended-Spectrum Beta-Lactamase-Producing Bacteria in Nonhospitalized Patients
verfasst von
R. Colodner
W. Rock
B. Chazan
N. Keller
N. Guy
W. Sakran
R. Raz
Publikationsdatum
01.03.2004
Verlag
Springer-Verlag
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 3/2004
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-003-1084-2

Weitere Artikel der Ausgabe 3/2004

European Journal of Clinical Microbiology & Infectious Diseases 3/2004 Zur Ausgabe

Announcements

March 2004

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.